Macrocure Priced, Nasdaq: MCUR
Israeli biotech developing white blood cell injections to treat hard-to-heal wounds.
Industry: Health Care
First Day Return: -27.5%
Industry: Health Care
MCUR
Israeli biotech developing white blood cell injections to treat hard-to-heal wounds.
| IPO Data | |
|---|---|
| IPO File Date | 06/23/2014 |
| Offer Price | $10.00 |
| Price Range $13.00 - $15.00 | |
| Offer Shares (mm) | 5.4 |
| Deal Size ($mm) | $54 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 07/30/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $54 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Petach Tikva, Israel |
| Founded | 2008 |
| Employees at IPO | 26 |
| Website www.macrocure.com | |
IPO News for Macrocure
Macrocure (MCUR) Performance
